Suproclone

Source: Wikipedia, the free encyclopedia.
Suproclone
Clinical data
ATC code
  • none
Identifiers
  • [6-(7-chloro-1,8-naphthyridin-2-yl)-5-oxo-3,7-dihydro-2H-[1,4]dithiino[2,3-c]pyrrol-7-yl] 4-propanoylpiperazine-1-carboxylate
JSmol)
  • O=C(N5CCN(C(=O)OC4C=1SCCSC=1C(=O)N4c2nc3nc(Cl)ccc3cc2)CC5)CC
  • InChI=1S/C22H22ClN5O4S2/c1-2-16(29)26-7-9-27(10-8-26)22(31)32-21-18-17(33-11-12-34-18)20(30)28(21)15-6-4-13-3-5-14(23)24-19(13)25-15/h3-6,21H,2,7-12H2,1H3 checkY
  • Key:IBAUKGNDWVSETP-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)

Suproclone is a

cyclopyrrolone family of drugs, developed by the French pharmaceutical company Rhône-Poulenc.[1] Other cyclopyrrolone drugs include zopiclone, pagoclone and suriclone
.

Suproclone is very similar in structure to the related drug

GABA), in a similar manner to other drugs of this class.[2][3]

References

  1. ^ Psychotropics.dk. "suproclone". Retrieved 24 August 2009.
  2. S2CID 85573551
    .
  3. ISBN 1-84184-052-1
    .
Stub icon

This sedative-related article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Suproclone&oldid=1175736704"